Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3889625 | 0.97 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Methyl Alcohol SCHEMBL28881402 | 0.91 | ALDH1A1 (0.44) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Naphthalene SCHEMBL11519928 | 0.88 | CYP2A6 (0.44) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL11816645 | 0.86 | KCNN4 (0.38) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL5498484 | 0.79 | KCNN4 (0.47) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL8440794 | 0.78 | CA4 (0.54) | — | |
| SCHEMBL11439383 | 0.76 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL9245544 | 0.73 | CYP1A2 (0.44) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL3889984 | 0.73 | MAPK1 (0.50) | KCNN4ALDH1A1TSHRMAPK1TAAR1 | |
| SCHEMBL2125552 | 0.71 | KCNN4 (0.41) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 504 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473252-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2025-11-18 | — | — | US | claimed |
| US-12338326-B2 | Polyamides with pendent optical absorbers and related methods | XEROX CORPORATION (US) | 2025-06-24 | — | — | US | claimed |
| CN-119977783-A | Synthesis method of oxaloacetic acid | 上海高准医药有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-20250042841-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2025-02-06 | — | — | US | claimed |
| CN-118388329-B | Tapentadol Process for the preparation of intermediates | 江苏海洋大学 | 2024-11-15 | — | — | CN | claimed |
| CN-112457487-B | Polyamide with overhanging optical absorbers and related methods | 施乐公司 | 2024-10-01 | — | — | CN | claimed |
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2024-08-20 | — | — | US | claimed |
| CN-118388329-A | Preparation method of tapentadol intermediate | 江苏海洋大学 | 2024-07-26 | — | — | CN | claimed |
| CN-116463159-B | Antioxidant additive, preparation method and application thereof | 中国石油天然气股份有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-118359540-A | Method for producing tolfenpyrad insecticide | 新沂市永诚化工有限公司 | 2024-07-19 | — | — | CN | claimed |
| EP-0458309-A2 | Dicyclopentadiene activation method and polymerization composition | NIPPON ZEON CO., LTD. (JP) | 1991-11-27 | — | — | EP | claimed |
| US-4908420-A | Hydrogenating, polymerizing unsaturated alkyl chain-containing norbornene containing compound | NIPPON OIL COMPANY, LTD. (JP) | 1990-03-13 | — | — | US | claimed |
| EP-0352772-A2 | Method for preparing resin having light color | NIPPON OIL CO., LTD. (JP) | 1990-01-31 | — | — | EP | claimed |
| US-4891456-A | Method for preparing norbornene structure compound | NIPPON OIL CO., LTD. (JP) | 1990-01-02 | — | — | US | claimed |
| EP-0298408-A1 | Method for preparing norbornene structure compound | NIPPON OIL CO. LTD. (JP) | 1989-01-11 | — | — | EP | claimed |
| US-4307232-A | Preparation of dialkyl- and diarylphosphonoalkanoic acids and substituted acrylic acids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-12-22 | — | — | US | claimed |
| US-4252925-A | HYDROCARBYLMETAL CATALYST | TOYO SODA MANUFACTURING CO., LTD. (JP) | 1981-02-24 | — | — | US | claimed |
| US-4247699-A | REACTION OF AN ISATOIC ANHYDRIDE WITH MALONONITRILE FOLLOWED BY TREATMENT WITH A STRONG ACID OR BASE | PFIZER INC. (US) | 1981-01-27 | — | — | US | claimed |
| US-4031130-A | Aliphatic β-keto esters | AGFA-GEVAERT, A.G. (DT) | 1977-06-21 | — | — | US | claimed |
| US-4029616-A | Polymer composition of ethylenic compounds and pullulan | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12473252-B2 | Processes for the preparation of deuterated D-serine | PSPH, SRR, DHPS | KCNN4 4813/4885ALDH1A1 3327/4885TSHR 3758/4885 |
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | PSPH, SRR, DHPS | KCNN4 4813/4885ALDH1A1 3327/4885TSHR 3758/4885 |
| US-20250042841-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | PSPH, SRR, DHPS | KCNN4 4813/4885ALDH1A1 3327/4885TSHR 3758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.